LIVE Public of India  •  Pan-India Citizen Newsroom  •  Verified Reporting
support@publicofindia.in Membership
BREAKING
Submit your story — verified, policy-led, privacy-first publishing Hindi & English news updated every 15 minutes from across India Members get priority review, profile badge & creator dashboard Public of India is a private platform — not a government website Submit your story — verified, policy-led, privacy-first publishing Hindi & English news updated every 15 minutes from across India Members get priority review, profile badge & creator dashboard Public of India is a private platform — not a government website
Home  /  BUSINESS  /  FDA Investigates Cancer Risk Associated With No...
BUSINESS Verified

FDA Investigates Cancer Risk Associated With Novartis' Zolgensma Gene Therapy

India • 12h ago • Source: publicofindia

In medicine, one truth transcends time: a drug's worth is measured not merely by how effectively it fights disease, but also by how safely it does so. One medicine that has recently drawn the FDA's attention over emerging safety concerns is Novartis Inc.

This is a summary. For the full story, refer to the original source. Public of India presents verified citizen-relevant reporting.